• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 S 蛋白 D614G 变异体与中和抗体相互作用的分子特征:一种计算方法。

Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutralizing antibodies: A computational approach.

机构信息

Department of Biochemistry and Biotechnology, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana; Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana.

Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana.

出版信息

Infect Genet Evol. 2021 Jul;91:104815. doi: 10.1016/j.meegid.2021.104815. Epub 2021 Mar 24.

DOI:10.1016/j.meegid.2021.104815
PMID:33774178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7987576/
Abstract

The D614G variant of SARS-CoV-2 S-protein emerged in early 2020 and quickly became the dominant circulating strain in Europe and its environs. The variant was characterized by the higher viral load, which is not associated with disease severity, higher incorporation into the virion, and high cell entry via ACE-2 and TMPRSS2. Previous strains of the coronavirus and the current SARS-CoV-2 have demonstrated the selection of mutations as a mechanism of escaping immune responses. In this study, we used molecular dynamics simulation and MM-PBSA binding energy analysis to provide insights into the behaviour of the D614G S-protein at the molecular level and describe the neutralization mechanism of this variant. Our results show that the D614G S-protein adopts distinct conformational dynamics which is skewed towards the open-state conformation more than the closed-state conformation of the wild-type S-protein. Residue-specific variation of amino acid flexibility and domain-specific RMSD suggest that the mutation causes an allosteric conformational change in the RBD. Evaluation of the interaction energies between the S-protein and neutralizing antibodies show that the mutation may enhance, reduce or not affect the neutralizing interactions depending on the neutralizing antibody, especially if it targets the RBD. The results of this study have shed insights into the behaviour of the D614G S-protein at the molecular level and provided a glimpse of the neutralization mechanism of this variant.

摘要

SARS-CoV-2 刺突蛋白 D614G 变体于 2020 年初出现,并迅速成为欧洲及其周边地区的主要流行株。该变体的特点是病毒载量较高,与疾病严重程度无关,更高比例地整合到病毒粒子中,以及通过 ACE-2 和 TMPRSS2 实现高细胞进入。以前的冠状病毒株和当前的 SARS-CoV-2 已经证明了突变的选择是逃避免疫反应的一种机制。在这项研究中,我们使用分子动力学模拟和 MM-PBSA 结合能分析,从分子水平上深入了解 D614G S 蛋白的行为,并描述该变体的中和机制。我们的结果表明,D614G S 蛋白采用了独特的构象动力学,其开放构象的倾向性大于野生型 S 蛋白的闭合构象。残基特异性氨基酸灵活性变化和结构域特异性 RMSD 表明,该突变导致 RBD 发生变构构象变化。评估 S 蛋白与中和抗体之间的相互作用能表明,该突变可能增强、减弱或不影响中和相互作用,具体取决于中和抗体,尤其是针对 RBD 的中和抗体。这项研究的结果深入了解了 D614G S 蛋白在分子水平上的行为,并为该变体的中和机制提供了一些见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e539/7987576/63292811f519/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e539/7987576/1d320adcee1d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e539/7987576/26ef2bac3380/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e539/7987576/d8bab639d685/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e539/7987576/b5d922bfbc8d/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e539/7987576/5aa6009d1f8b/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e539/7987576/ba91cf6047d6/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e539/7987576/ed83d7593dd0/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e539/7987576/63292811f519/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e539/7987576/1d320adcee1d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e539/7987576/26ef2bac3380/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e539/7987576/d8bab639d685/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e539/7987576/b5d922bfbc8d/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e539/7987576/5aa6009d1f8b/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e539/7987576/ba91cf6047d6/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e539/7987576/ed83d7593dd0/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e539/7987576/63292811f519/gr8_lrg.jpg

相似文献

1
Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutralizing antibodies: A computational approach.SARS-CoV-2 S 蛋白 D614G 变异体与中和抗体相互作用的分子特征:一种计算方法。
Infect Genet Evol. 2021 Jul;91:104815. doi: 10.1016/j.meegid.2021.104815. Epub 2021 Mar 24.
2
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.SARS-CoV-2 刺突 RBD 中的 V367F 突变增强了与人类 ACE2 受体的结合亲和力,从而提高了病毒的感染性。
J Virol. 2021 Jul 26;95(16):e0061721. doi: 10.1128/JVI.00617-21.
3
The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization.SARS-CoV-2 Y453F 变异 mink 变体显示出 ACE-2 亲和力的明显增加,但不会挑战抗体中和。
J Biol Chem. 2021 Jan-Jun;296:100536. doi: 10.1016/j.jbc.2021.100536. Epub 2021 Mar 11.
4
Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies.两种强效 SARS-CoV-2 中和抗体对新兴 B.1.351 和 B.1.1.7 变体的适应结构基础。
Structure. 2021 Jul 1;29(7):655-663.e4. doi: 10.1016/j.str.2021.05.014. Epub 2021 Jun 9.
5
Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.ACE2 表达中的遗传变异性对 SARS-CoV-2 刺突 D614G 突变进化动态的影响。
Genes (Basel). 2020 Dec 24;12(1):16. doi: 10.3390/genes12010016.
6
Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.几种膜结合丝氨酸蛋白酶对 SARS-CoV-2 S 蛋白的启动作用可以解释增强的病毒感染力和全身性 COVID-19 感染。
J Biol Chem. 2021 Jan-Jun;296:100135. doi: 10.1074/jbc.REV120.015980. Epub 2020 Dec 6.
7
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.SARS-CoV-2 从高中和性的 COVID-19 恢复期血浆中逃逸。
Proc Natl Acad Sci U S A. 2021 Sep 7;118(36). doi: 10.1073/pnas.2103154118.
8
Molecular insights into the binding interactions and energetics of the omicron spike variant with hACE2 and a neutralizing antibody.奥密克戎刺突变体与 hACE2 和中和抗体结合相互作用和能量学的分子见解。
J Struct Biol. 2024 Jun;216(2):108087. doi: 10.1016/j.jsb.2024.108087. Epub 2024 Mar 16.
9
Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.刺突蛋白结构特征、决定病毒进入宿主细胞的物种特异性血管紧张素转换酶 2 残基,以及奥密克戎 BA.1、BA.1.1、BA.2 和 BA.3 变异株的抗体中和逃逸。
J Virol. 2022 Sep 14;96(17):e0114022. doi: 10.1128/jvi.01140-22. Epub 2022 Aug 24.
10
In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.基于 SARS-CoV-2 刺突糖蛋白与 ACE-2 受体同源物和人类 TLR 相互作用的比较特征的计算机研究。
J Med Virol. 2020 Oct;92(10):2105-2113. doi: 10.1002/jmv.25987. Epub 2020 May 17.

引用本文的文献

1
The influence of single-point mutation D614G on the binding process between human angiotensin-converting enzyme 2 and the SARS-CoV-2 spike protein-an atomistic simulation study.单点突变D614G对人血管紧张素转换酶2与SARS-CoV-2刺突蛋白结合过程的影响——一项原子模拟研究
RSC Adv. 2023 Mar 28;13(15):9800-9810. doi: 10.1039/d3ra00198a. eCollection 2023 Mar 27.
2
Novel coronavirus mutations: Vaccine development and challenges.新型冠状病毒突变:疫苗开发与挑战。
Microb Pathog. 2022 Dec;173(Pt A):105828. doi: 10.1016/j.micpath.2022.105828. Epub 2022 Oct 13.
3
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy.

本文引用的文献

1
The SARS-CoV-2 Spike variant D614G favors an open conformational state.SARS-CoV-2 刺突变异株 D614G 有利于构象呈开放状态。
Sci Adv. 2021 Apr 16;7(16). doi: 10.1126/sciadv.abf3671. Print 2021 Apr.
2
Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant.由SARS-CoV-2非D614G变体引发的人类中和抗体对SARS-CoV-2 D614G变体提供交叉保护。
Clin Transl Immunology. 2021 Feb 22;10(2):e1241. doi: 10.1002/cti2.1241. eCollection 2021.
3
Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile.
意大利南部卡拉布里亚地区新冠病毒感染动态及SARS-CoV-2变体的演变
Front Microbiol. 2022 Jul 28;13:934993. doi: 10.3389/fmicb.2022.934993. eCollection 2022.
4
D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity.D614G 突变与 SARS-CoV-2:对 S 蛋白结构、功能、感染性和免疫性的影响。
Appl Microbiol Biotechnol. 2021 Dec;105(24):9035-9045. doi: 10.1007/s00253-021-11676-2. Epub 2021 Nov 10.
5
Impact of mutations in SARS-COV-2 spike on viral infectivity and antigenicity.SARS-COV-2 刺突突变对病毒感染力和抗原性的影响。
Brief Bioinform. 2022 Jan 17;23(1). doi: 10.1093/bib/bbab375.
6
SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors.新冠病毒刺突糖蛋白反应性 T 细胞可从接种过新冠疫苗的供者中轻易扩增。
Immun Inflamm Dis. 2021 Dec;9(4):1452-1467. doi: 10.1002/iid3.496. Epub 2021 Jul 27.
7
N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白N端结构域突变与接种疫苗个体中和抗体有效性降低相关。
J Med Virol. 2021 Oct;93(10):5726-5728. doi: 10.1002/jmv.27181. Epub 2021 Jul 14.
智利接触 SARS-CoV-2 个体的中和抗体反应的见解。
Sci Adv. 2021 Feb 12;7(7). doi: 10.1126/sciadv.abe6855. Print 2021 Feb.
4
SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity.SARS-CoV-2 的 D614G 刺突突变提高了与 ACE2 的结合亲和力,从而增加了进入效率。
Nat Commun. 2021 Feb 8;12(1):848. doi: 10.1038/s41467-021-21118-2.
5
D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction.D614G 突变改变了 SARS-CoV-2 刺突构象,并增强了 S1/S2 连接处的蛋白酶切割。
Cell Rep. 2021 Jan 12;34(2):108630. doi: 10.1016/j.celrep.2020.108630. Epub 2020 Dec 26.
6
Genomic analysis of SARS-CoV-2 reveals local viral evolution in Ghana.SARS-CoV-2 的基因组分析揭示了加纳的本地病毒进化。
Exp Biol Med (Maywood). 2021 Apr;246(8):960-970. doi: 10.1177/1535370220975351. Epub 2020 Dec 16.
7
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization.D614G 刺突突变增加了 SARS-CoV-2 对中和作用的敏感性。
Cell Host Microbe. 2021 Jan 13;29(1):23-31.e4. doi: 10.1016/j.chom.2020.11.012. Epub 2020 Dec 1.
8
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.评估 SARS-CoV-2 刺突突变 D614G 对传染性和致病性的影响。
Cell. 2021 Jan 7;184(1):64-75.e11. doi: 10.1016/j.cell.2020.11.020. Epub 2020 Nov 19.
9
SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.SARS-CoV-2 刺突蛋白 D614G 突变增加了病毒粒子刺突密度和感染力。
Nat Commun. 2020 Nov 26;11(1):6013. doi: 10.1038/s41467-020-19808-4.
10
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.通过 SARS-CoV-2 刺突蛋白变体逃避中和抗体。
Elife. 2020 Oct 28;9:e61312. doi: 10.7554/eLife.61312.